@misc{indiciae421f6b193f95,
  title = {Safety, Pharmacokinetics, and Pharmacodynamics of Single-Dose Programmed Cell Death Protein 1 Inhibitor, Budigalimab, in People With HIV-1 With Antiretroviral Therapy-Suppressed Viral Load.},
  author = {Tanaya R Vaidya and Till Geib and Jacob P Lalezari and Christopher Bettacchi and Cynthia C Brinson and Peter J Ruane and Heide Betman and Fei Zhou and Preethi Krishnan and Nael M Mostafa},
  year = {2026},
  doi = {10.1093/infdis/jiag142},
  url = {https://pubmed.ncbi.nlm.nih.gov/41955081/},
  note = {Source identifier: 41955081}
}